Health-Related Quality of Life and Symptom Management Research Sponsored by the National Cancer Institute
- 10 November 2007
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (32) , 5128-5132
Abstract
For almost 30 years, the National Cancer Institute (NCI) has sponsored health-related quality-of-life (HRQOL) measures in cancer research as a means of including the patient's experience. The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations.Keywords
This publication has 9 references indexed in Scilit:
- Pain Management in Hospitalized Cancer Patients: A Systematic ReviewJournal of Clinical Oncology, 2007
- Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2007
- Intraperitoneal Cisplatin and Paclitaxel in Ovarian CancerNew England Journal of Medicine, 2006
- Quality-of-Life Assessment in the Symptom Management Trials of the National Cancer Institute-Supported Community Clinical Oncology ProgramJournal of Clinical Oncology, 2005
- Outcomes Assessment in Cancer2004
- Pain: impediments and suggestions for solutions.JNCI Monographs, 2004
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- RTOG's first quality of life study—RTOG 90-20: A phase II trial of external beam radiation with etanidazole for locally advanced prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trialsQuality of Life Research, 1992